首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Icotinib/osimertinibAcquired resistance: 2 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2021年
/ 1853卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-021-95099-1
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:233 / 233
相关论文
共 50 条
[21]
Erlotinib/gefitinib/osimertinibAcquired drug resistance: 3 case reports
Reactions Weekly,
2019,
1752
(1)
: 158
-
158
[22]
OsimertinibAcquired resistance and acquired genetic alterations: 49 case reports
Reactions Weekly,
2025,
2047
(1)
: 364
-
364
[23]
OsimertinibAcquired resistance: case report
Reactions Weekly,
2021,
1836
(1)
: 620
-
620
[24]
Afatinib/gefitinib/osimertinibAcquired resistance in non-small cell lung cancer: 2 case reports
Reactions Weekly,
2019,
1741
(1)
: 16
-
16
[25]
OsimertinibAcquired resistance: case report
Reactions Weekly,
2019,
1771
(1)
: 235
-
235
[26]
OsimertinibAcquired resistance: case report
Reactions Weekly,
2021,
1841
(1)
: 202
-
202
[27]
OsimertinibAcquired resistance: case report
Reactions Weekly,
2022,
1910
(1)
: 381
-
381
[28]
OsimertinibAcquired resistance: case report
Reactions Weekly,
2020,
1821
(1)
: 202
-
202
[29]
OsimertinibAcquired resistance: case report
Reactions Weekly,
2019,
1762
(1)
: 283
-
283
[30]
Bevacizumab/gefitinib/osimertinibAcquired drug resistance and lack of efficacy: 3 case reports
Reactions Weekly,
2023,
1953
(1)
: 112
-
112
←
1
2
3
4
5
→